Partner Content Partner Content HPAPI 2020 conference to discuss containment solutions and A... HPAPI Conference
Events Partner Content Highly Potent Active Pharmaceutical Ingredients (HPAPI) SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020.
Partner Content Partner Content The Latest Innovations in HPAPI Manufacturing Technologies HPAPI Technologies
Partner Content Partner Content The need for a blueprint emergency plan to avoid a HPAPI cri... HPAPI Safety Strategies
Partner Content Partner Content Insights into HPAPI Containment and Banding Strategies HPAPI USA Updates
News Akebia joins GSK in US market for oral CKD anaemia drugs The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.